<DOC>
	<DOCNO>NCT00461305</DOCNO>
	<brief_summary>The purpose study investigate efficacy ethinylestradiol intracyclic bleed profile patient dysmenorrhea investigate long term safety</brief_summary>
	<brief_title>Safety Study Ethinylestradiol/Drospirenone Dysmenorrhea</brief_title>
	<detailed_description>The `` drospirenone 3 mg/ethinylestradiol 20 μg ( 13 cycle ) '' group treat oral administration 52 week , 13 cycle . The `` drospirenone 3 mg/ethinylestradiol 30 μg ( 6 cycle ) '' group treat oral administration 24 week , 6 cycle . The trial sponsor Bayer Yakuhin , Ltd .</detailed_description>
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Drospirenone ethinyl estradiol combination</mesh_term>
	<criteria>Patients age 20 year old obtain informed consent Patients normal menstrual cycle ( 25 38 day ) late two menses final enrollment Patients total dysmenorrheal score least 3 point twice late menstruation final enrollment Patients ovarian chocolate cyst Patients fibroid need treated Patients estrogendependent tumor patient cervical cancer suspect cervical cancer Patients undiagnosed abnormal vaginal bleeding Patients thrombophlebitis , pulmonary embolism , cerebrovascular disease , coronary artery disease history diseases Patients age 35 year old smoke least 15 cigarette per day Patients migraine accompany prodromata Patients pulmonary hypertension valvular heart disease Patients regularly take nutritional product contain St. John 's Wort Patients underwent surgical treatment endometriosis within 2 month prior screen Patients may need regularly use analgesic therapeutic objective relief pain dysmenorrhea study ( occasional use permit )</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Dysmenorrhea</keyword>
	<keyword>Intracyclic bleeding</keyword>
	<keyword>Drospirenone ( DRSP )</keyword>
	<keyword>Ethinylestradiol</keyword>
</DOC>